Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Heller, G."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 44
Tytuł:
Treatment of Early Glottic cancer with Transoral Laser Microsurgery: An Australian Experience.
Autorzy:
Ahmadi N; Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW Australia.; Department of ENT, Westmead Hospital, Sydney, NSW Australia.; Faculty of Medicine, University of New South Wales, Sydney, NSW Australia.
Stone D; Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.
Stokan M; Department of Anaesthetics, Westmead Hospital, Sydney, NSW Australia.
Coleman H; Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.; Douglass Hanly Moir Pathology, Sydney, NSW Australia.
Heller G; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW Australia.
Smith M; Department of ENT, Westmead Hospital, Sydney, NSW Australia.
Riffat F; Department of ENT, Westmead Hospital, Sydney, NSW Australia.
Kudpaje A; Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.; Cytecare Cancer Hospitals, Bangalore, India.
Veness M; Crown Princess Cancer Care Centre, Westmead hospital, Sydney, NSW Australia.; Sydney Medical School, University of Sydney, Sydney, NSW Australia.
Palme CE; Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW Australia.; Department of ENT, Westmead Hospital, Sydney, NSW Australia.; Sydney Medical School, University of Sydney, Sydney, NSW Australia.
Pokaż więcej
Źródło:
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India [Indian J Otolaryngol Head Neck Surg] 2023 Jun; Vol. 75 (2), pp. 661-667. Date of Electronic Publication: 2022 Dec 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Do patients with femoroacetabular impingement syndrome who undergo hip arthroscopy display improved alpha angle (magnetic resonance imaging) and radiographic hip morphology?
Autorzy:
Thirumaran AJ; Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Murphy NJ; Sydney Musculoskeletal Health, Kolling Institute of Medical Research, University of Sydney, Camperdown, New South Wales, Australia.; Department of Orthopedic Surgery, John Hunter Hospital, New Lambton, New South Wales, Australia.
Eyles JP; Sydney Musculoskeletal Health, Kolling Institute of Medical Research, University of Sydney, Camperdown, New South Wales, Australia.; Department of Rheumatology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Linklater JM; Department of Musculoskeletal Imaging, Castlereagh Imaging, St Leonards, New South Wales, Australia.
Reichenbach S; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Department of Rheumatology, Immunology and Allergology, University Hospital and University of Bern, Bern, Switzerland.; Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Schmaranzer F; Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Lerch TD; Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Venkatesha V; Northern Sydney Local Health District Executive, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Heller G; Department of Statistics, Faculty of Science and Engineering, Macquarie University, Sydney, New South Wales, Australia.
O'Donnell J; Hip Arthroscopy Australia, Melbourne, Victoria, Australia.; St Vincent's Private Hospital, Melbourne, Victoria, Australia.
Hunter DJ; Sydney Musculoskeletal Health, Kolling Institute of Medical Research, University of Sydney, Camperdown, New South Wales, Australia.; Department of Rheumatology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2023 Feb; Vol. 26 (2), pp. 354-359. Date of Electronic Publication: 2022 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Femoracetabular Impingement*/diagnostic imaging
Femoracetabular Impingement*/surgery
Humans ; Arthroscopy ; Treatment Outcome ; Magnetic Resonance Imaging ; Radiography ; Hip Joint/diagnostic imaging ; Hip Joint/surgery ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer.
Autorzy:
Lemberger L; Cell Signaling and Metabolism Networks Program, Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
Wagner R; Cell Signaling and Metabolism Networks Program, Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.
Heller G; Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
Pils D; Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Grunt TW; Cell Signaling and Metabolism Networks Program, Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, 1090 Vienna, Austria.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Dec 05; Vol. 14 (23). Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CDK6 Degradation Is Counteracted by p16 in AML.
Autorzy:
Schmalzbauer BS; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Thondanpallil T; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
Schirripa A; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Sperl CM; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Mayer IM; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Knab VM; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Nebenfuehr S; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Zojer M; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Mueller AC; CeMM-Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
Fontaine F; CeMM-Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
Klampfl T; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Sexl V; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Kollmann K; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Mar 18; Vol. 14 (6). Date of Electronic Publication: 2022 Mar 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells.
Autorzy:
Grandits AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Bromberger S; Skin and Endothelium Research Division, Department of Dermatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Reinoehl BA; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Tomasich E; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Schossleitner K; Skin and Endothelium Research Division, Department of Dermatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Fuereder T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jan 19; Vol. 23 (3). Date of Electronic Publication: 2022 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/genetics
MDS1 and EVI1 Complex Locus Protein*/genetics
Squamous Cell Carcinoma of Head and Neck*/genetics
Cell Line, Tumor ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Invasiveness ; Transcription Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.
Autorzy:
Liebert A; School of Medical Sciences, University of Sydney, Camperdown, Australia. .; Governance and Research Department, Sydney Adventist Hospital, Wahroonga, Australia. .
Bicknell B; Faculty of Health Sciences, Australian Cathlic University, North Sydney, Australia.
Laakso EL; Mater Research Institute, South Brisbane, Australia.; Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
Heller G; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.; Department of Mathematics and Statistics, Macquarie University, Macquarie Park, Australia.
Jalilitabaei P; Department of Anatomy, University of Sydney, Camperdown, Australia.
Tilley S; Lymphoedema And Laser Therapy, Stepney, Australia.
Mitrofanis J; Department of Anatomy, University of Sydney, Camperdown, Australia.
Kiat H; Faculty of medicine, Health and Human Sciences, Macquarie University, Macquarie Park, Australia.; Faculty of Medicine, University of NSW, Kensington, Australia.; Cardiac Health Institute, Sydney, Australia.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2021 Jul 02; Vol. 21 (1), pp. 256. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Low-Level Light Therapy*
Parkinson Disease/*therapy
COVID-19 ; Humans ; Prospective Studies ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Autorzy:
Schmidt U; Research Institute of Molecular Pathology, Dr. Bohr-Gasse 3, A-1030, Vienna, Austria.
Heller G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria.
Timelthaler G; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090, Vienna, Austria.
Heffeter P; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090, Vienna, Austria.
Somodi Z; Department of Oncology, Bacs-Kiskun County Teaching Hospital, Kecskemet, Hungary.; Present Address: Parexel International, 2 Federal St, Billerica, MA, USA.
Schweifer N; Boehringer-Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Sibilia M; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090, Vienna, Austria.
Berger W; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090, Vienna, Austria.
Csiszar A; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090, Vienna, Austria. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2021 Feb 17; Vol. 40 (1), pp. 69. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Cytokines/*genetics
Neoplasm Proteins/*genetics
Neoplasms/*genetics
Proto-Oncogene Proteins c-met/*genetics
Animals ; Cell Line, Tumor ; Cytokines/metabolism ; Disease Progression ; Epithelial-Mesenchymal Transition ; Female ; Gene Amplification ; Heterografts ; Humans ; Mice ; Mice, SCID ; NIH 3T3 Cells ; Neoplasm Invasiveness ; Neoplasm Proteins/metabolism ; Neoplasms/metabolism ; Neoplasms/pathology ; Proto-Oncogene Proteins c-met/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The added value of new covariates to the brier score in cox survival models.
Autorzy:
Heller G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering, 485 Lexington Avenue, New York, New York, 10017, USA. .
Pokaż więcej
Źródło:
Lifetime data analysis [Lifetime Data Anal] 2021 Jan; Vol. 27 (1), pp. 1-14. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Proportional Hazards Models*
Survival Analysis*
Algorithms ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
microRNA-146a controls age-related bone loss.
Autorzy:
Saferding V; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria.
Hofmann M; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria.; Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Brunner JS; Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Niederreiter B; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.
Timmen M; Department of Regenerative Musculoskeletal Medicine, Institute of Musculoskeletal Medicine (IMM), University Hospital Münster, Münster, Germany.
Magilnick N; Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, California, USA.
Hayer S; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.
Heller G; Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Steiner G; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.
Stange R; Department of Regenerative Musculoskeletal Medicine, Institute of Musculoskeletal Medicine (IMM), University Hospital Münster, Münster, Germany.
Boldin M; Department of Molecular and Cellular Biology, Beckman Research Institute, City of Hope, Duarte, California, USA.
Schabbauer G; Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Weigl M; TAmiRNA GmbH, Vienna, Austria.; Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Hackl M; TAmiRNA GmbH, Vienna, Austria.; Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Grillari J; Austrian Cluster for Tissue Regeneration, Vienna, Austria.; Department of Biotechnology, Institute for Molecular Biotechnology, BOKU - University of Natural Resources and Life Sciences, Vienna, Austria.; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in AUVA Research Center, Vienna, Austria.
Smolen JS; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.
Blüml S; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2020 Nov; Vol. 19 (11), pp. e13244. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs/*genetics
Osteoporosis/*genetics
Animals ; Bone Resorption/genetics ; Bone Resorption/pathology ; Cell Differentiation/physiology ; Epigenesis, Genetic ; Female ; Male ; Mice ; MicroRNAs/metabolism ; Osteoblasts/cytology ; Osteoporosis/pathology ; Wnt-5a Protein/metabolism ; Wnt1 Protein/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Measuring the temporal prognostic utility of a baseline risk score.
Autorzy:
Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .
Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Heller G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło:
Lifetime data analysis [Lifetime Data Anal] 2020 Oct; Vol. 26 (4), pp. 856-871. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Prognosis*
Proportional Hazards Models*
Risk Assessment/*methods
Computer Simulation ; Humans ; Risk Factors ; Time
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
IDO1 Paneth cells promote immune escape of colorectal cancer.
Autorzy:
Pflügler S; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Svinka J; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Scharf I; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Crncec I; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Filipits M; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Charoentong P; Institute of Bioinformatics, Medical University Innsbruck, Biocenter, 6020, Innsbruck, Austria.; Department of Medical Oncology, National Center for Tumor diseases, University Hospital Heidelberg, 69120, Heidelberg, Germany.; German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Tschurtschenthaler M; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK.; Center for Translational Cancer Research (TranslaTUM), Technical University of Munich, 81675, Munich, Germany.
Kenner L; Ludwig Boltzmann Institute for Cancer Research LBICR, 1090, Vienna, Austria.; Institute of Clinical Pathology, Medical University of Vienna, 1090, Vienna, Austria.; Department of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria.
Awad M; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Stift J; Institute of Clinical Pathology, Medical University of Vienna, 1090, Vienna, Austria.
Schernthanner M; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Bischl R; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Herndler-Brandstetter D; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Glitzner E; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Moll HP; Department of Physiology, Center of Physiology and Pharmacology, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090, Vienna, Austria.
Casanova E; Ludwig Boltzmann Institute for Cancer Research LBICR, 1090, Vienna, Austria.; Department of Physiology, Center of Physiology and Pharmacology, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090, Vienna, Austria.
Timelthaler G; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Sibilia M; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Gnant M; Department of Surgery, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.
Lax S; Department of Pathology, Hospital Graz II, 8020, Graz, Austria.; Institute of Pathology and Molecular Pathology, Johannes Kepler University, 4040, Linz, Austria.
Thaler J; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, 4600, Wels, Austria.
Müller M; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210, Vienna, Austria.
Strobl B; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210, Vienna, Austria.
Mohr T; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Kaser A; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK.
Trajanoski Z; Institute of Bioinformatics, Medical University Innsbruck, Biocenter, 6020, Innsbruck, Austria.
Heller G; Division of Oncology, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria.
Eferl R; Institute of Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, 1090, Vienna, Austria. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2020 May 22; Vol. 3 (1), pp. 252. Date of Electronic Publication: 2020 May 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms/*pathology
Immune Tolerance/*immunology
Indoleamine-Pyrrole 2,3,-Dioxygenase/*metabolism
Intestinal Neoplasms/*pathology
Paneth Cells/*immunology
STAT1 Transcription Factor/*physiology
Animals ; Colorectal Neoplasms/etiology ; Colorectal Neoplasms/immunology ; Colorectal Neoplasms/metabolism ; Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics ; Intestinal Neoplasms/immunology ; Intestinal Neoplasms/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia.
Autorzy:
Gluexam T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Grandits AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Schlerka A; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Nguyen CH; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Etzler J; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Finkes T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Fuchs M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Scheid C; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Hackl H; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innrain 80, 6020 Innsbruck, Austria.
Harrer N; Department for Cancer Research, Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria.
Sill H; Division of Hematology, Medical University of Graz, Auenbruggerplatz 38, 8036 Graz, Austria.
Koller E; Third Medical Department, Hanusch Hospital, Heinrich Collinstrasse 30, 1140 Vienna, Austria.
Stoiber D; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090 Vienna, Austria.; Division Pharmacology, Department Pharmacology, Physiology and Microbiology, Karl Landsteiner University of Health Sciences, Dr.-Karl-Dorrek-Straße 30, 3500 Krems, Austria.
Sommergruber W; Department of Biotechnology, University of Applied Sciences, Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; Comprehensive Cancer Center, Spitalgasse 23, 1090 Vienna, Austria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2019 Nov 20; Vol. 20 (23). Date of Electronic Publication: 2019 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Neoplasm*
Calcitonin Gene-Related Peptide/*metabolism
Calcitonin Receptor-Like Protein/*metabolism
Leukemia, Myeloid, Acute/*metabolism
Neoplastic Stem Cells/*metabolism
Animals ; Antibiotics, Antineoplastic/pharmacology ; Antibiotics, Antineoplastic/therapeutic use ; Apoptosis/drug effects ; Calcitonin Receptor-Like Protein/antagonists & inhibitors ; Cell Line, Tumor ; Daunorubicin/pharmacology ; Daunorubicin/therapeutic use ; Dipeptides/pharmacology ; Dipeptides/therapeutic use ; Female ; Hematopoietic Stem Cells/metabolism ; Humans ; Leukemia, Myeloid, Acute/drug therapy ; Male ; Mice ; Mice, Inbred C57BL ; Middle Aged ; Piperazines ; Quinazolines/pharmacology ; Quinazolines/therapeutic use ; Signal Transduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness.
Autorzy:
Nguyen CH; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Glüxam T; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Schlerka A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Bauer K; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.; Institute of Science and Technology Austria, Vienna, Austria.
Grandits AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Hackl H; Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Dovey O; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Zöchbauer-Müller S; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Cooper JL; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Vassiliou GS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Stoiber D; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Wieser R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. .; Comprehensive Cancer Center, Vienna, Austria. .
Heller G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. gerwin.heller@meduniwien.ac.at.; Comprehensive Cancer Center, Vienna, Austria. gerwin.heller@meduniwien.ac.at.; Institute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria. gerwin.heller@meduniwien.ac.at.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Jun 24; Vol. 9 (1), pp. 9139. Date of Electronic Publication: 2019 Jun 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute/*genetics
Leukemia, Myeloid, Acute/*pathology
Suppressor of Cytokine Signaling Proteins/*genetics
Animals ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Mice ; Neoplastic Stem Cells/pathology ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.
Autorzy:
Goldberg JD; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Zheng J; c Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Ratan R; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Small TN; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.; d Department of Pediatrics, Bone Marrow Transplantation Service , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Lai KC; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Boulad F; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.; d Department of Pediatrics, Bone Marrow Transplantation Service , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Castro-Malaspina H; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Giralt SA; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Jakubowski AA; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Kernan NA; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.; d Department of Pediatrics, Bone Marrow Transplantation Service , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
O'Reilly RJ; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.; d Department of Pediatrics, Bone Marrow Transplantation Service , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Papadopoulos EB; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Young JW; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
van den Brink MR; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Heller G; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.; c Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Perales MA; a Department of Medicine , Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center , New York , NY , USA.; b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Aug; Vol. 58 (8), pp. 1859-1871. Date of Electronic Publication: 2017 Jan 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Lymphocyte Depletion*
T-Lymphocytes/*immunology
T-Lymphocytes/*metabolism
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Female ; Hematologic Neoplasms/immunology ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/therapy ; Humans ; Immunity, Cellular ; Immunophenotyping ; Lymphocyte Count ; Male ; Middle Aged ; Prognosis ; Survival Analysis ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Time Factors ; Transplantation Conditioning ; Transplantation, Homologous ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.
Autorzy:
Altenberger C; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Heller G; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Ziegler B; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Tomasich E; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Marhold M; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Topakian T; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Müllauer L; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Heffeter P; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria.
Lang G; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Division of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.
End-Pfützenreuter A; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Division of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Döme B; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Division of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.; Department of Thoracic Oncology and Tumor Biology, National Koranyi Institute of Pulmonology, Budapest, Hungary.; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.
Arns BM; Department of Respiratory and Critical Care Medicine and Ludwig Boltzmann Institute for COPD, Otto-Wagner Hospital, Vienna, Austria.
Klepetko W; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Division of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Zielinski CC; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Zöchbauer-Müller S; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2017 Jan 05; Vol. 16 (1), pp. 1. Date of Electronic Publication: 2017 Jan 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Gene Expression Regulation, Neoplastic*
Transcription, Genetic*
Carcinoma, Non-Small-Cell Lung/*genetics
Lung Neoplasms/*genetics
Microtubule Proteins/*genetics
Proteins/*genetics
Animals ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Cell Proliferation ; Cell Survival/genetics ; Databases, Genetic ; Disease Models, Animal ; Gene Silencing ; Heterografts ; High-Throughput Nucleotide Sequencing ; Humans ; Immunohistochemistry ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Mice ; Microtubule Proteins/metabolism ; Polymorphism, Single Nucleotide ; Proteins/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Sequence Deletion ; Tumor Burden ; Tumor Stem Cell Assay
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8 T cells for adoptive immunotherapy of cancer and infections.
Autorzy:
Hasan AN; Department of Pediatrics, Division of Bone Marrow Transplantation.; Department of Pediatrics, Immunology Program, Sloan-Kettering Institute.
Selvakumar A; Department of Pediatrics, Immunology Program, Sloan-Kettering Institute.
Shabrova E; Department of Pediatrics, Division of Bone Marrow Transplantation.
Liu XR; Department of Pediatrics, Immunology Program, Sloan-Kettering Institute.
Afridi F; Department of Pediatrics, Division of Bone Marrow Transplantation.
Heller G; Department of Epidemiology and Biostatistics.
Riviere I; The Center for Cell Engineering.
Sadelain M; The Center for Cell Engineering.
Dupont B; Department of Pediatrics, Immunology Program, Sloan-Kettering Institute.; Division of Bone Marrow Transplantation, Memorial Sloan-Kettering Cancer Center New York, NY, USA.
O'Reilly RJ; Department of Pediatrics, Division of Bone Marrow Transplantation. .; Department of Pediatrics, Immunology Program, Sloan-Kettering Institute. .; The Center for Cell Engineering. .
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2016 Nov; Vol. 186 (2), pp. 249-265. Date of Electronic Publication: 2016 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy, Adoptive*
CD8-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*metabolism
Interleukin-15/*metabolism
Lymphocyte Activation/*immunology
Receptors, Interleukin-15/*metabolism
Apoptosis/genetics ; Apoptosis/immunology ; Biomarkers ; Cell Line, Transformed ; Cytokines/metabolism ; Cytomegalovirus/immunology ; Cytotoxicity, Immunologic ; Epitopes, T-Lymphocyte/immunology ; Humans ; Immunologic Memory ; Infections/immunology ; Infections/metabolism ; Infections/therapy ; Interleukin-15/genetics ; Neoplasms/immunology ; Neoplasms/metabolism ; Neoplasms/therapy ; Protein Binding ; Receptors, Interleukin-15/genetics ; T-Cell Antigen Receptor Specificity/immunology ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Estimating the concordance probability in a survival analysis with a discrete number of risk groups.
Autorzy:
Heller G; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA. .
Mo Q; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Pokaż więcej
Źródło:
Lifetime data analysis [Lifetime Data Anal] 2016 Apr; Vol. 22 (2), pp. 263-79. Date of Electronic Publication: 2015 May 29.
Typ publikacji:
Journal Article
MeSH Terms:
Models, Statistical*
Survival Analysis*
Algorithms ; Computer Simulation ; Humans ; Kaplan-Meier Estimate ; Male ; Probability ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/therapy ; Risk
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
EVI1 promotes tumor growth via transcriptional repression of MS4A3.
Autorzy:
Heller G; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. gerwin.heller@meduniwien.ac.at.; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. gerwin.heller@meduniwien.ac.at.
Rommer A; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Steinleitner K; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Etzler J; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Hackl H; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innrain 80, 6020, Innsbruck, Austria. .
Heffeter P; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .; Department of Medicine I, Institute of Cancer Research, and Research Platform 'Translational Cancer Therapy Research', Borschkegasse 8A, 1090, Vienna, Austria. .
Tomasich E; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Filipits M; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .; Department of Medicine I, Institute of Cancer Research, and Research Platform 'Translational Cancer Therapy Research', Borschkegasse 8A, 1090, Vienna, Austria. .
Steinmetz B; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Topakian T; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Klingenbrunner S; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Ziegler B; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Spittler A; Core Facility Flow Cytometry & Surgical Research Laboratories, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .
Zöchbauer-Müller S; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Berger W; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .; Department of Medicine I, Institute of Cancer Research, and Research Platform 'Translational Cancer Therapy Research', Borschkegasse 8A, 1090, Vienna, Austria. .
Wieser R; Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .; Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2015 Mar 21; Vol. 8, pp. 28. Date of Electronic Publication: 2015 Mar 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Proliferation*/physiology
Transcription, Genetic*
Cell Cycle Proteins/*metabolism
DNA-Binding Proteins/*metabolism
Gene Expression Regulation, Neoplastic/*physiology
Leukemia, Myeloid/*pathology
Membrane Proteins/*metabolism
Transcription Factors/*metabolism
Animals ; Cell Cycle Proteins/genetics ; Cell Line, Tumor ; Chromatin Immunoprecipitation ; DNA-Binding Proteins/genetics ; Fluorescent Antibody Technique ; Gene Knockdown Techniques ; Heterografts ; Humans ; Immunohistochemistry ; Leukemia, Myeloid/genetics ; Leukemia, Myeloid/metabolism ; MDS1 and EVI1 Complex Locus Protein ; Male ; Membrane Proteins/genetics ; Mice ; Mice, SCID ; Oligonucleotide Array Sequence Analysis ; Proto-Oncogenes/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Transcription Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation.
Autorzy:
Tarek N; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Gallagher MM; Immunology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Chou JF; Department of Epidemiology-Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Lubin MN; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Heller G; Department of Epidemiology-Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Barker JN; 1] Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Weill Medical College of Cornell University, New York, NY, USA.
Hsu KC; 1] Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Weill Medical College of Cornell University, New York, NY, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jan; Vol. 50 (1), pp. 150-2. Date of Electronic Publication: 2014 Oct 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Cord Blood Stem Cell Transplantation*
HLA Antigens*/blood
HLA Antigens*/genetics
Haplotypes*
Hematologic Neoplasms*/blood
Hematologic Neoplasms*/genetics
Hematologic Neoplasms*/therapy
Receptors, KIR*/blood
Receptors, KIR*/genetics
Transplantation Chimera*/blood
Transplantation Chimera*/genetics
Adolescent ; Adult ; Aged ; Allografts ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Risk factors for frequent falls in people with Parkinson's disease.
Autorzy:
Paul SS; The George Institute for Global Health, Sydney, NSW, Australia Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
Allen NE; Faculty of Health Sciences, The University of Sydney, Lidcombe, NSW, Australia.
Sherrington C; The George Institute for Global Health, Sydney, NSW, Australia Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
Heller G; Statistics Department, Faculty of Science, Macquarie University, North Ryde, NSW, Australia.
Fung VS; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia Movement Disorders Unit, Department of Neurology, Westmead Hospital, Westmead, NSW, Australia.
Close JC; Neuroscience Research Australia, UNSW, Randwick, NSW, Australia Prince of Wales Clinical School, UNSW, Prince of Wales Hospital, Randwick, NSW, Australia.
Lord SR; Neuroscience Research Australia, UNSW, Randwick, NSW, Australia.
Canning CG; Faculty of Health Sciences, The University of Sydney, Lidcombe, NSW, Australia.
Pokaż więcej
Źródło:
Journal of Parkinson's disease [J Parkinsons Dis] 2014; Vol. 4 (4), pp. 699-703.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Accidental Falls*
Parkinson Disease/*complications
Postural Balance/*physiology
Sensation Disorders/*etiology
Aged ; Area Under Curve ; Female ; Humans ; Male ; Middle Aged ; Neurologic Examination ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 44

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies